<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">931</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2024-23-4-174-181</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>LITERATURE REVIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The inftuence of thrombotic events in pediatric maxillofacial pathology on the results of surgical treatment</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние тромботических событий при челюстно-лицевой патологии детского возраста на результаты хирургического лечения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4364-8937</contrib-id><name-alternatives><name xml:lang="en"><surname>Leonov</surname><given-names>N. P.</given-names></name><name xml:lang="ru"><surname>Леонов</surname><given-names>Н. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Nikolay P. Leonov</bold>, Cand. Med. Sci., an anesthesiologist – intensivist at the Department of Anesthesiology and Critical Care with Surgical Unit</p><p><italic>1 Samory Mashela St., Moscow 117997</italic></p></bio><bio xml:lang="ru"><p><bold>Леонов Николай Петрович</bold>, канд. мед. наук, врач-анестезиологреаниматолог отделения анестезиологии и реанимации с операционным блоком</p><p><italic>117997, Москва, ул. Саморы Машела, 1</italic></p></bio><email>nikoleonov@ya.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9558-4234</contrib-id><name-alternatives><name xml:lang="en"><surname>Pavlova</surname><given-names>D. E.</given-names></name><name xml:lang="ru"><surname>Павлова</surname><given-names>Д. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow </italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0231-1617</contrib-id><name-alternatives><name xml:lang="en"><surname>Trakhtman</surname><given-names>P. E.</given-names></name><name xml:lang="ru"><surname>Трахтман</surname><given-names>П. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow </italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5230-5725</contrib-id><name-alternatives><name xml:lang="en"><surname>Spiridonova</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Спиридонова</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow </italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">The Dmitry Rogachev  National  Medical  Research  Center  of  Pediatric  Hematology,  Oncology  and  Immunology  of  Ministry  of  Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">The Morozov Children's Clinical Hospital of the Department of Health of Moscow</institution></aff><aff><institution xml:lang="ru">ГБУЗ г. Москвы «Морозовская детская городская клиническая больница Департамента здравоохранения г. Москвы»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Russian University of Medicine of Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Российский университет медицины» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-12-13" publication-format="electronic"><day>13</day><month>12</month><year>2024</year></pub-date><volume>23</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>174</fpage><lpage>181</lpage><history><date date-type="received" iso-8601-date="2024-12-18"><day>18</day><month>12</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-12-18"><day>18</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/931">https://hemoncim.com/jour/article/view/931</self-uri><abstract xml:lang="en"><p>Local and generalized thrombotic events can affect patient outcomes and quality of life. The purpose of our scoping review was to investigate the influence of thrombotic events in pediatric maxillofacial pathology on the results of surgical treatment. The search for publications was carried out in December 2023 in the PubMed information system. Two authors independently reviewed the studies and extracted data for analysis. The study included 8 publications out of 654 found. The pediatric cohort in the selected studies was mixed with adult patients. Insufficient information was obtained to carry out a meta-analysis and definitively answer the research question. It seems likely that the anatomical and pathophysiological features of maxillofacial pathology, pharmacological effects of therapy and methods of surgical correction may influence the development and progression of local intravascular coagulopathy. There are no recommendations on the choice of standard or integral hemostasis tests for the diagnosis and monitoring of coagulopathy in this pathology. The use of low-molecular-weight heparins can reduce the clinical manifestations of local intravascular coagulopathy.</p></abstract><trans-abstract xml:lang="ru"><p>Локальные и генерализованные тромботические события могут влиять на результаты лечения и качество жизни пациентов. Целью нашего систематического обзора литературы было исследование влияния тромботических событий при челюстно-лицевой патологии детского возраста на результаты хирургического лечения. Поиск публикаций проведен в декабре 2023 г. в информационной системе PubMed. Два автора независимо рассмотрели исследования и извлекли данные для анализа. В исследование вошли 8 публикаций из 654 найденных. Педиатрическая когорта в отобранных исследованиях была смешана со взрослыми пациентами. Получено недостаточно информации для выполнения метаанализа и четкого ответа на вопрос исследования. Представляется вероятным, что анатомо-патофизиологические особенности челюстно-лицевой патологии, фармакологические эффекты терапии и методы хирургической коррекции могут влиять на развитие и прогрессирование локальной внутрисосудистой коагулопатии. Рекомендации по выбору стандартных или интегральных тестов гемостаза для диагностики и мониторинга коагулопатии при данной патологии отсутствуют. Применение низкомолекулярных гепаринов может уменьшить клинические проявления локальной внутрисосудистой коагулопатии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>thrombosis</kwd><kwd>maxillofacial pathology</kwd><kwd>children</kwd><kwd>coagulopathy</kwd><kwd>maxillofacial surgery</kwd><kwd>vascular malformations</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>тромбоз</kwd><kwd>челюстно-лицевая патология</kwd><kwd>дети</kwd><kwd>коагулопатия</kwd><kwd>челюстно-лицевая хирургия</kwd><kwd>сосудистые мальформации</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Kushner A., West W.P., Khan Suheb M.Z., Pillarisetty L.S. Virchow Triad. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Martinelli I., Bucciarelli P., Mannucci P.M. Thrombotic risk factors: basic pathophysiology. Crit Care Med 2010; 38 (2 Suppl): S3–9. DOI: 10.1097/CCM.0b013e3181c9cbd9</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Crochemore T., Görlinger K., Lance M.D. Early Goal-Directed Hemostatic Therapy for Severe Acute Bleeding Management in the Intensive Care Unit: A Narrative Review. Anesth Analg 2024; 138 (3): 499–513. DOI: 10.1213/ANE.0000000000006756</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Tricco A.C., Lillie E., Zarin W., O'Brien K.K., Colquhoun H., Levac D., et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 2018; 169 (7): 467–73. DOI: 10.7326/M18-0850</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Rossell-Perry P. Flap Necrosis after Palatoplasty in Patients with Cleft Palate. Biomed Res Int 2015; 2015: 516375. DOI: 10.1155/2015/516375</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Omesiete W.I., Walker J.A. 3rd, Yu J.C. Venous Thromboembolism Incidence After Craniofacial Surgery. Ann Plast Surg 2018; 80 (5): 561–4. DOI: 10.1097/SAP.0000000000001353</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Forouzanfar T., Heymans M.W., van Schuilenburg A., Zweegman S., Schulten E.A. Incidence of venous thromboembolism in oral and maxillofacial surgery: a retrospective analysis. Int J Oral Maxillofac Surg 2010; 39 (3): 256–9. DOI: 10.1016/j.ijom.2009.10.024</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Zhang C., Sun J., Zhu H., Xu L., Ji T., He Y., et al. Microsurgical free flap reconstructions of the head and neck region: Shanghai experience of 34 years and 4640 flaps. Int J Oral Maxillofac Surg 2015; 44 (6): 675– 84. DOI: 10.1016/j.ijom.2015.02.017</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hoffman G.R., Islam S., Eisenberg R.L. Microvascular reconstruction of the mouth, jaws, and face: experience of an Australian oral and maxillofacial surgery unit. J Oral Maxillofac Surg 2012; 70 (5): e371– 7. DOI: 10.1016/j.joms.2012.01.016</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Jia Y., Zhao Y., Chen X. Clinical and histopathological review of 229 cases of ranula. J Huazhong Univ Sci Technolog Med Sci 2011; 31 (5): 717. DOI: 10.1007/s11596-011-0589-7</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Jonas R., Schaal T., Krimmel M., Gülicher D., Reinert S., Hoffmann J. Monitoring in microvascular tissue transfer by measurement of oxygen partial pressure: four years experience with 125 microsurgical transplants. J Craniomaxillofac Surg 2013; 41 (4): 303–9. DOI: 10.1016/j.jcms.2012.10.008</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Mack J.M., Verkamp B., Richter G.T., Nicholas R., Stewart K., Crary S.E. Effect of sirolimus on coagulopathy of slow-flow vascular malformations. Pediatr Blood Cancer 2019; 66 (10): e27896. DOI: 10.1002/pbc.27896</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Mazereeuw-Hautier J., Syed S., Leisner R.I., Harper J.I. Extensive venous/lymphatic malformations causing life-threatening haematological complications. Br J Dermatol 2007; 157 (3): 558–63. DOI: 10.1111/j.1365-2133.2007.08003.x</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Sepúlveda P., Zavala A., Zúñiga P. Factors associated with thrombotic complications in pediatric patients with vascular malformations. J Pediatr Surg 2017; 52 (3): 400– 4. DOI: 10.1016/j.jpedsurg.2016.10.048</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ricci K.W., Chute C., Hammill A.M., Dasgupta R., Patel M. Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy. Pediatr Blood Cancer 2020; 67 (10): e28277. DOI: 10.1002/pbc.28277</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Mack J.M., Pierce C.D., Richter G.T., Spray B.J., Nicholas R., Lewis P.S., et al. Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography. Pediatr Blood Cancer 2021; 68 (2): e28824. DOI: 10.1002/pbc.28824</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Mason K.P., Neufeld E.J., Karian V.E., Zurakowski D., Koka B.V., Burrows P.E. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. AJR Am J Roentgenol 2001; 177 (6): 1359–63. DOI: 10.2214/ajr.177.6.1771359</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Garfein E., Doscher M., Tepper O., Gill J., Gorlick R., Smith R.V. Reconstruction of the pediatric midface following oncologic resection. J Reconstr Microsurg 2015; 31 (5): 336–42. DOI: 10.1055/s-0035-1544181</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Arat Y.O., Mawad M.E., Boniuk M. Orbital venous malformations: current multidisciplinary treatment approach. Arch Ophthalmol 2004; 122 (8): 1151–8. DOI: 10.1001/archopht.122.8.1151</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Callahan A.B., Meyers P.M., Garrity J.A., Son J.H., Petris C., Kazim M. Low-Flow Arterialized Venous Malformations of the Orbit. Ophthalmic Plast Reconstr Surg 2017; 33 (4): 256–60. DOI: 10.1097/IOP.0000000000000734</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Dompmartin A., Acher A., Thibon P., Tourbach S., Hermans C., Deneys V., et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 2008; 144 (7): 873–7. DOI: 10.1001/archderm.144.7.873</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ali S., Weiss C.R., Sinha A., Eng J., Mitchell S.E. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Phlebology 2016; 31 (9): 603–9. DOI: 10.1177/0268355516633380</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Jia R., Xu S., Huang X., Song X., Pan H., Zhang L., et al. Pingyangmycin as first-line treatment for lowflow orbital or periorbital venous malformations: evaluation of 33 consecutive patients. JAMA Ophthalmol 2014; 132 (8): 942–8. DOI: 10.1001/jamaophthalmol.2013.8229</mixed-citation></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Reshetov I.V. Tumors of organs of head and neck: technology of treatment and rehabilitation of patients: tissue reconstruction. M.: 2016. 520 p. (In. Russ.)</mixed-citation><mixed-citation xml:lang="ru">Решетов И.В. Опухоли органов головы и шеи: технология лечения и реабилитация пациентов: реконструкция тканей. М., 2016. 520 с.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Rumyantsev A.G., Varfolomeeva S.R., Grachev N.S., Karachunskiy A.I., Novichkova G.A. Principles and tools of evidence-based medicine in pediatric hematology/ oncology. Doctor.ru 2015; 10 (111): 6–13. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Румянцев А.Г., Варфоломеева С.Р., Грачев Н.С., Карачунский А.И., Новичкова Г.А. Принципы и инструменты доказательной медицины в детской гематологии/онкологии. Доктор.ру 2015; 10 (111): 6–13.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
